Oct 2026· iScience· Vol 29, pp. 117732· 0 citations· 66 references
Medicine
TL;DR
This study provides a basis for vascular/metabolic disease prevention policies and dietary interventions in Western Europe and North America and identified several potential causal links.
Abstract
Summary Ischemic heart disease (IHD), ischemic stroke (IS), type 2 diabetes mellitus (T2DM), and lower-extremity vascular disease are leading causes of disability in Western Europe and North America, but their diet-attributable burden remains unclear. Using Global Burden of Disease (GBD) 2023 data, we assessed the association between the Socio-demographic Index (SDI) and the vascular/metabolic disease burden and compared the cross-regional burden through multi-dimensional time-trend, risk contribution, and projection analyses. Mendelian randomization (MR) tested causal diet effects on disease subtypes. Frontier analysis showed diet-related IHD and IS burden declined with SDI, while T2DM increased. By 2023, Western Europe had a lower burden than North America. Processed meat and whole grain dominated T2DM and IHD burden, respectively. Joinpoint analysis revealed declining trends. Projections to 2035 indicated North America remains higher. MR identified several potential causal links. This study provides a basis for vascular/metabolic disease prevention policies and dietary interventions in Western Europe and North America.
Although age-standardized incidence and mortality declined, especially in high-sociodemographic index countries, absolute numbers increased due to demographic momentum, and forecasts suggest continued increases in absolute cases and deaths through 2035 despite declining standardized rates.
Liang-Lei Hou, Yi-Wei Huang, Bin Lin et al.· Medicine· 0 citations
Objective Peripheral arterial disease (PAD) presents a significant clinical and public health challenge. This study aimed to comprehensively analyze and compare the burden trends and disparities of PAD attributable to metabolic risks in China and G20 countries. Methods Disability-adjusted life years (DALYs), age-standa...
Jie Yuan, Bao-Lei Guo, Fan Li et al.· International Journal of Pub...· 0 citations
BACKGROUND
Global chronic kidney disease (CKD) burden from metabolic risks has risen steadily. Using 2021 Global Burden of Disease (GBD) data, this study examines 1990-2021 spatiotemporal trends and regional disparities in CKD to inform prevention.
METHODS
We analyzed 1990-2021 GBD data on metabolic-related CKD burde...
Ke-Rong Jiang, Li-Min Yin, Yong-Sheng Pan et al.· Journal of the National Medi...· 1 citation
High systolic blood pressure (HSBP) is a major risk factor for ischemic stroke (IS), promoting atherosclerosis, vessel occlusion, cerebral small-vessel damage, and thrombosis. However, data on the temporal evolution of HSBP-attributable IS burden are limited. This study analyzes the global HSBP-attributable IS burd...
Yi-Fu Ma, Dan Li, Fang-Ling Sun et al.· Annals of Medicine & Sur...· 0 citations
Introduction / Background:
Lead exposure is a major environmental health risk and an underrecognized contributor to cardiovascular disease in South Asia. Country-level evidence remains limited despite rapid population growth, industrialization, and varied environmental regulations across the region.
Research Qu...
M. Hasan, Hamayel Qadir, Hammad Chola et al.· Circulation· 0 citations
Hypertensive heart disease (HHD) is a major cardiovascular consequence of prolonged hypertension. This ecological study assessed global, regional, and national trends in HHD burden and its projected trajectories. The Global Burden of Disease Study 2021 provided estimates of Global Burden of Disease-defined HHD prevalen...
Chang-Shun Yan, Su Hu, Hang-Yu Cao et al.· Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.